Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Pseudoephedrine, PPA reporting exemption

This article was originally published in The Tan Sheet

Executive Summary

Pseudoephedrine, PPA reporting exemption: Drug Enforcement Administration publishes interim rule Oct. 17 providing a temporary exemption from chemical registration requirements to the distributors of pseudoephedrine and phenylpropanolamine products. Registration requirements for distributors of pseudoephedrine and PPA are effective Oct. 3 under the Comprehensive Methamphetamine Control Act. Those required by the law to register with DEA in order to handle pseudoephedrine and PPA products must submit an application by Dec. 3 in order to continue distribution until final action has been taken on the application. Comments on the exemption are due Dec. 16. In a separate, same-day notice, DEA announces it is waiving a portion of the registration fee for non-retail distributors of pseudoephedrine, PPA and combination ephedrine drugs, effective immediately...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087669

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel